CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- EFFECT Other Notice of Effectiveness
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Agreement ended · Unregistered share sale
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.65 ($3,240)
- 4 Open-market buy Director bought 15,000 shares at $0.57 ($8,589)
- 8-K Event Delisting notice
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 30,000 shares at $0.55 ($16,500)
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $0.68 ($1,710)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $0.67 ($2,016)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $0.69 ($3,450)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 15 of 74 · 1,465 filings